Middle East respiratory syndrome program (Benevira)

N/A

Report date: 2025/01/26 17:32:43

Base Information

Drug NameMiddle East respiratory syndrome program (Benevira)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespirovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBenevira Inc
China Registration ClassN/A

Develop Information

Active CompaniesBenevira Inc
Inactive CompaniesN/A
Active IndicationsRespirovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A